Foundayo is a small molecule whereas Zepbound and Wegovy are peptides, which require more intensive manufacturing processes, a barrier Ricks thinks will hinder generic versions of Wegovy that have recently launched in some other countries, including India
Colton Jones, MD, the lead researcher and a hematology and medical oncology fellow at the University of Texas at San Antonio, and colleagues analyzed the health records of nearly 8,800 people with breast cancer and obesity taking both hormonal therapy and GLP-1s
These genetic insightsinterpreted by qualified providersmay contextualize why certain individuals respond robustly to GLP-1 therapy while others require dose adjustments or alternative approaches
Semaglutide and tirzepatide have slightly different mechanisms and side effect profiles
It may also help increase GLP-1 levels
doi: 10.1016/j.jand.2017.06.364